Landscapes / Companies
Olema Oncology, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials
Trials
5 active
6 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2028Phase 3 trial completes | |||
| Next date | Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, Metastatic Breast Cancer and 11 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 May 2027Phase 1 trial completes | |||
| Next date | 30 May 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) and 4 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021